Enterocolitis: Clinical Trials

2 trials for Enterocolitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 withdrawn. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Withdrawn 2

Follow Enterocolitis: new trials by email Literature Review of Enterocolitis trials Research Report on Enterocolitis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prediction of NEC With Urinary iFABP
Assessment of urinary iFABP, Administration of enteral feedings - Prematurity, Necrotizing Enterocolitis
Phase 2WithdrawnLoma Linda University2014-11-012015-05-14
Safety and Clinical Effectiveness of Oral Probiotic MIYA-BM to Prevent Recurrent Clostridium Difficile Infections
MIYA-BM Fine Granules (CBM588), Placebo Fine Granules (without CBM588) - Clostridium Difficile Infection
Phase 2WithdrawnOsel, Inc.2010-02-012013-11-11

Narrower conditions

Bacterial Infections (1)  ·  Clostridium Infections (1)  ·  Colitis (1)  ·  Colonic Diseases (1)  ·  Diarrhea (1)  ·  Digestive System Diseases (1)  ·  Enterocolitis, Necrotizing (1)  ·  Enterocolitis, Pseudomembranous (1)  ·  Gastroenteritis (1)  ·  Gastrointestinal Diseases (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Intestinal Diseases (1)  ·  Premature Birth (1)

Broader conditions

Bacterial Infections and Mycoses (1)  ·  Digestive System Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Gastroenteritis (1)  ·  Gastrointestinal Diseases (1)  ·  Infections (1)  ·  Intestinal Diseases (1)  ·  Obstetric Labor Complications (1)  ·  Obstetric Labor, Premature (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Pregnancy Complications (1)  ·  Signs and Symptoms (1)  ·  Signs and Symptoms, Digestive (1)  ·  Urogenital Diseases (1)

Sponsors

Loma Linda University (1)  ·  Osel, Inc. (1)

Countries

United States (1)

Top investigators

Gerald Gollin, MD (1)  ·  Lynne V. McFarland, Ph.D. (1)